Good morning, everyone, and welcome to the middle of the week. A sunny day is at hand, but, of course, the workload is in full swing as meetings and deadlines loom. We share your dilemma as our own to-do list grows by the minute. Of course, we are coping by brewing another delicious cup of stimulation and invite you to join us. Meanwhile, we hope you accomplish much and, by the way, drop us a line if you hear anything interesting...
Ranbaxy Drops Some Applications Filed With FDA (MarketWatch)
EU Financial Crisis Continues To Hit Drug Pricing (Pharma Times)
Novartis Gleevec Case In India Delayed Until Sept. 11 (Reuters)
NICE Rejects Avastin For Breast Cancer (The Independent)
Gilead Discontinues PAH Drug After Missing Study Goal (Dow Jones)
Statins Cut Risk Of Pancreatitis (MedPage Today)
Roche Struggles With Boniva Supplies (InPharm)
EDITOR'S NOTE: Please check this post for updates during the dya